The FDA approved oral sodium zirconium cyclosilicate (ZS-9), to be marketed as Lokelma, for the treatment of hyperkalemia.
FDA approves new hyperkalemia drug Lokelma
FDA approves new hyperkalemia drug Lokelma
FDA approves new hyperkalemia drug Lokelma
The FDA approved oral sodium zirconium cyclosilicate (ZS-9), to be marketed as Lokelma, for the treatment of hyperkalemia.